NextCure, Inc.NXTCNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-1.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-9.42%
Q3 202567.83%
Q2 2025-144.24%
Q1 20255.40%
Q4 2024-0.55%
Q3 202425.08%
Q2 20249.95%
Q1 2024-18.25%
Q4 2023-1.16%
Q3 202319.92%
Q2 2023-10.95%
Q1 20236.96%
Q4 20228.52%
Q3 2022-5.53%
Q2 202213.02%
Q1 2022-21.62%
Q4 20215.53%
Q3 20210.32%
Q2 2021-8.79%
Q1 2021-6.93%
Q4 20205.54%
Q3 2020-12.81%
Q2 2020-249.06%
Q1 2020189.07%
Q4 2019-29.56%
Q3 2019-2.59%
Q2 2019-33.57%
Q1 201910.30%
Q4 2018-20.18%
Q3 2018-9.16%
Q2 2018-4.70%
Q1 20180.00%